Mithra and Gynial Sign Commercialization Agreement for Myring™ in Switzerland

  • Mithra grants license for its vaginal contraceptive ring to Gynial for commercialization in Switzerland
  • Strengthening its partnership with Women’s Health specialist Gynial, already responsible for the Austrian market
  • Large-scaled global commercialization of Myring™ after first successful launches in Europe

Liege, Belgium, 05 May 2020 – 7 :30  CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces that it has entered into a license and supply agreement (LSA) with Gynial GmbH for the commercialization of its hormonal contraceptive ring Myring™ in Switzerland.